Primary record
4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]-benzoic acid; 4-[3,5-Bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid; 4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid; Asunra; Deferasirox; Exjade; ICL 670; ICL 670A
- 库存
- 7,839 克
- 纯度
- 98.9 %
- CAS
- 201530-41-8
化合物标识与属性
- CAS
- 201530-41-8
- PubChem CID
- 214348
- SMILES
- C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O
- Canonical SMILES
- O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1
名称与同义词
- Deferasirox
- Exjade
- 201530-41-8
- Deferasiroxum
- Jadenu
- Osveral
- Jadenu Sprinkle
- Deferasirox-d4
- Deferasorox
- ICL670A
- ICL 670
- Deferasirox oral
- ICL-670A
- Deferasirox CRS
- ICL670
- ICL-670
- Deferasiroxum [INN-Latin]
- ICL 670A
- Deferasirox [INN]
- Exjade (TN)
- Jadenu (TN)
- Deferasirox (Exjade)
- Deferasirox (Exjade)?
- Deferasirox (Standard)
- V8G4MOF2V9
- Deferasirox [USAN:INN]
- Deferasirox, ICL670
- RefChem:54942
- UNII-V8G4MOF2V9
- AC1NUU0E
- AC1O1JMP
- DEFERASIROX [MI]
- Deferasirox Oral Granules
- DEFERASIROX [JAN]
- Deferasirox Fe3+ chelate
- DEFERASIROX [HSDB]
- DEFERASIROX [USAN]
- DTXSID1048596
- CHEBI:49005
- D0Q5UQ
- DEFERASIROX [VANDF]
- Deferasirox [USAN:INN:JAN]
- C21H15N3O4
- DEFERASIROX [MART.]
- MFCD09951804
- SCHEMBL61756
- SCHEMBL62042
- DEFERASIROX [USP-RS]
- DEFERASIROX [WHO-DD]
- DTXCID1028522
- HSDB 7844
- MLS003915634
- MLS006010080
- 4-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid
- BOFQWVMAQOTZIW-UHFFFAOYSA-N
- CGP-72670
- Deferasirox (JAN/USAN/INN)
- DEFERASIROX [EMA EPAR]
- Methyl 3,3-dimethoxypropionate
- CHEMBL550348
- orb1308568
- SCHEMBL1071867
- SCHEMBL29381781
- 4-[3,5-bis(2-hydroxyphenyl)
- 4-[3,5-Bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid
- CTK8F0690
- DEFERASIROX [ORANGE BOOK]
- V03AC03
- DEFERASIROX [EP MONOGRAPH]
- GLXC-21393
- HMS3655A04
- HMS5079D16
- BCP05341
- EX-A4091
- ZINC1481815
- Tox21_112926
- BDBM50088376
- EBC-12794
- EBC-50057
- HY-17359R
- MFCD09751362
- NCGC00181754-01
- NP3629
- s1712
- ZINC14880008
- AKOS015855839
- AKOS015902587
- AKOS025312553
- C21-H15-N3-O4
- Deferasirox for system suitability CRS
- Tox21_112926_1
- ZINC100022643
- ZINC100504305
- ZINC100504309
- AC-8972
- ACN-028608
- AN-5418
- BCP9000594
- Benzoic acid, 4-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]-
- CCG-268337
- CID:214348
- CID5493381
- CID6098188
- CS-0901
- CS-O-00300
- DB01609
- FB20882
- KE-0220
- SB18926
- Deferasirox(Discontinued,SeeC4X-1438)
- KS-00000G02
- 4-(3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl)benzoic acid
- NCGC00263572-01
- AK544293
- BC677677
- HY-17359
- PD087125
- SMR002544689
- SY032012
- 2-[(2S)-1-methoxypropan-2-yl]guanidine
- Deferasirox 100 microg/mL in Acetonitrile
- SID:376229606
- AB0020007
- AB0073018
- AB1008603
- LS-186571
- LS-187785
- A8639
- CAS-201530-41-8
- D5905
- FT-0601564
- FT-0665569
- NS00000461
- SW219752-1
- V0697
- 1044764-54-6
- J1.213.542D
- A10293
- D03669
- SBI-0654184.0001
- W-5422
- AB01565800_02
- 4-[bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid
- 530D418
- A814288
- Benzoic acid, 4-(3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl)-
- C415250
- EN300-26907573
- SR-01000931971
- I14-1968
- Q5251502
- SR-01000931971-2
- BRD-K97010173-001-04-1
- D000077588
- F0001-2380
- Z3041510169
- 4-(3,5-bis-(2-hydroxyphenyl)-(1,2,4)-triazol-1-yl)benzoic acid
- 4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid
- 4-{3,5-bis[(1E)-6-oxocyclohexa-2,4-dien-1-ylidene]-1,2,4-triazolidin-1-yl}benzoic acid
- 1133425-75-8
- 4-(3,5-Bis-(hydroxy-phenyl)-1,2,4-triazol-1-yl)-benzoic Acid
- 4-[3,5-Bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic acid
- 4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazole-1-yl]benzoic acid
- 4-(3,5-Bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl)benzoic acid
- 4-(3,5-Bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl)benzoicacid
- 4-[3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid
- 4-((3E,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl)benzoic acid
- 4-((3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl)benzoic acid
- 4-[(3E,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid
- 4-[(3z,5e)-3,5-bis(6-oxocyclohexa-2,4-dien-1ylidene)-1,2,4-triazolidin-1-yl] benzoic acid
- 4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]-benzoic acid; 4-[3,5-Bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid; 4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid; Asunra; Deferasirox; Exjade; ICL 670; ICL 670A
- 554435-97-1
- ICL670; IC-L670; ICL 670; ICL-670A; ICL670A; ICL 670A; CGP-72670; CGP72670;CGP 72670
- JBL